Sino-Korean Collaboration × Technology Sourcing

First Stop of the Visit to Korea: Heilongjiang Region & MAYLIN CLINIC Cheongdam in Korea

On May 30, 2024, DCELL / D+JU PN officially launched the Sino-Korean Clinical Research Center system, with the first visit to Korea group from the Heilongjiang region and MAYLIN CLINIC Cheongdam in Korea.

In the global skin beauty market, both China and Korea have always held significant positions. As a leading brand in the field of skin rejuvenation, DCELL / D+JU PN is fully committed to deepening its presence in the Korean market. This visit to Korea for technical sourcing aimed to engage in in-depth discussions on the differentiated demands of the Sino-Korean medical aesthetics market and the project integration and packaging experiences of Korean institutions, with the goal of bringing more insights and reflections to clinical technical exchanges and observations in the medical aesthetics field, thereby promoting the prosperous development of the industry.

Korean PR R&D Center Sourcing | In-Depth Visit

As a pioneer in the Asian medical aesthetics industry, Korea's market demand and consumer preferences play a guiding role in global beauty trends. The visit began with an exploration of the PR R&D Center, where we observed cutting-edge equipment and emerging technological trends, experiencing Korea's strong R&D capabilities. The R&D center has achieved significant results in research related to anti-aging, skin repair, and whitening, with several studies successfully transformed into popular market products.

DOT Technology Interaction × Medical Resonance

As a deep-sea research and repair brand in Korea, the core ingredients of Dcell / D+JU PN are extracted using DOT specialized technology. By controlling the number of migrating salmon individuals and strictly managing their life cycles, the extracted raw materials undergo processes such as crushing, drying, and packaging, ultimately producing a white powdered high-purity molecular substance with no rejection reactions.

From product development to market launch, DCELL / D+JU PN consistently prioritizes quality, continuously pursuing excellence and innovation. Its rich R&D experience, combined with a solid academic background, provides a strong guarantee for beauty seekers' aesthetic services.

Korean MAYLIN CLINIC Cheongdam | Multi-Dimensional Exchange

The visit to MAYLIN CLINIC Cheongdam in Korea facilitated in-depth exchanges, with discussions on Sino-Korean clinical experience becoming an important platform for promoting innovation in medical aesthetics technology. Dcell / D+JU PN not only focuses on product development but also emphasizes the effectiveness of products in clinical practice, continuously enhancing the clinical application value of its products to provide higher quality services for beauty seekers.

As the times evolve, the skin beauty markets of China and Korea are becoming increasingly prosperous, yet they also face challenges of differentiated demands and cultural integration.

Differentiated Demand Exchange in the Sino-Korean Skin Beauty Market

There are significant differences in demand between the skin beauty markets of China and Korea. Korean beauty seekers place greater emphasis on immediate product effects and technological content, tending to choose high-tech, high-efficacy beauty products. In contrast, Chinese beauty seekers are more concerned with product safety and long-term effects, preferring natural ingredients and gentle formulations.

DCELL / D+JU PN consistently upholds a scientific professional spirit, focusing on product safety and effectiveness, ensuring that its products can be effectively applied in different contexts, achieving true cross-cultural value transmission in medical aesthetics.

In-Depth Discussion on Korean Institutional Project Integration and Packaging Experience

Korean institutions have unique insights and strategies in the integration and packaging of medical aesthetics projects. Through multi-party cooperation and resource integration, they have created a series of high-end, professional aesthetic projects.

The Korean side emphasizes overall project planning and detailed execution. From market research and product development to market promotion, every step requires scientific planning and professional execution. Through this experience exchange, Dcell / D+JU PN will continue to innovate in the Sino-Korean markets.

The mutual exchange of market trends and excellent experiences in institutional projects between China and Korea injects new vitality into the development of both countries' medical aesthetics industries. Dcell will also continue to participate in academic exchange activities in both countries, exploring market trends and opportunities while sharing project experiences and innovative results.

Medical Boundaries × Endless Exploration

Through this visit to Korea, we gained a deeper understanding of the differentiated demands of the Sino-Korean skin beauty market and the integration experiences of institutional projects. In this vibrant and opportunity-filled era, DCELL / D+JU PN remains committed to scientific innovation as a driving force, and in the future, we will work together to forge innovation and excellence in the field of skin rejuvenation, striving to elevate Sino-Korean clinical technical exchanges to new heights.